Cannabidiol (Tiamat Australia)

N/A

Report date: 2025/05/15 20:00:08

Base Information

Drug NameCannabidiol (Tiamat Australia)
Drug Alias NameMRX-1
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonistsSerotonin 5-HT1 receptors modulators +[4] 
TargetsCannabinoid CB2 receptorCannabinoid CB1 receptorSerotonin 5-HT1 receptors +[4] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTiamat Australia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTiamat Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A